Suppr超能文献

重复给予小鼠γ-戊内酯(GVL)和γ-羟基丁酸(GHB)的效应:GHB和γ-氨基丁酸能系统的神经适应性变化

Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System.

作者信息

Frisoni Paolo, Corli Giorgia, Bilel Sabrine, Tirri Micaela, Gasparini Laura Camilla, Alfieri Letizia, Neri Margherita, De-Giorgio Fabio, Marti Matteo

机构信息

Unit of Legal Medicine, AUSL of Ferrara, Via Arturo Cassoli 30, 44121 Ferrara, Italy.

Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.

出版信息

Pharmaceuticals (Basel). 2023 Aug 30;16(9):1225. doi: 10.3390/ph16091225.

Abstract

BACKGROUND

Gamma-hydroxybutyric acid (GHB) at low dosages has anxiolytic effects and promotes REM sleep and low-wave deep sleep. In the U.S., the legal form of GHB is prescribed to adults suffering from narcolepsy-associated cataplexy; the sodium salt of GHB is reserved for alcohol-addiction treatment. GHB is also a molecule of abuse and recreational use, it is a controlled substance in several countries, so gamma-valerolactone (GVL) has frequently been used as a legal substitute for it. GHB's abuse profile is most likely attributable to its anxiolytic, hypnotic, and euphoric properties, as well as its widespread availability and inexpensive/low cost on the illicit market.

METHODS

Our study is focused on evaluating the potential effects on the mouse brain after repeated/prolonged administration of GHB and GVL at a pharmacologically active dose (100 mg/kg) through behavioral study and immunohistochemical analysis using the markers tetraspanin 17 (TSPAN17), aldehyde dehydrogenase 5 (ALDH5A1), Gamma-aminobutyric acid type A receptor (GABA-A), and Gamma-aminobutyric acid type B receptor (GABA-B).

RESULTS

Our findings revealed that prolonged administration of GHB and GVL at a pharmacologically active dose (100 mg/kg) can have effects on a component of the mouse brain, the intensity of which can be assessed using immunohistochemistry. The findings revealed that long-term GHB administration causes a significant plastic alteration of the GHB signaling system, with downregulation of the putative binding site (TSPAN17) and overexpression of ALDH5A1, especially in hippocampal neurons. Our findings further revealed that GABA-A and GABA-B receptors are downregulated in these brain locations, resulting in a greater decrease in GABA-B expression.

CONCLUSIONS

The goal of this study, from the point of view of forensic pathology, is to provide a new methodological strategy for better understanding the properties of this controversial substance, which could help us better grasp the unknown mechanism underlying its abuse profile.

摘要

背景

低剂量的γ-羟基丁酸(GHB)具有抗焦虑作用,并能促进快速眼动睡眠和低波深度睡眠。在美国,GHB的合法形式被开给患有发作性睡病伴猝倒症的成年人;GHB的钠盐则用于酒精成瘾治疗。GHB也是一种滥用和用于消遣的物质,在几个国家它是受管制物质,因此γ-戊内酯(GVL)经常被用作其合法替代品。GHB的滥用情况很可能归因于其抗焦虑、催眠和欣快特性,以及其在非法市场上的广泛可得性和低廉成本。

方法

我们的研究专注于通过行为学研究以及使用四跨膜蛋白17(TSPAN17)、醛脱氢酶5(ALDH5A1)、γ-氨基丁酸A型受体(GABA-A)和γ-氨基丁酸B型受体(GABA-B)等标志物的免疫组化分析,评估以药理活性剂量(100毫克/千克)重复/长期给予GHB和GVL后对小鼠大脑的潜在影响。

结果

我们的研究结果显示,以药理活性剂量(100毫克/千克)长期给予GHB和GVL会对小鼠大脑的一个组成部分产生影响,其影响强度可通过免疫组化进行评估。研究结果表明,长期给予GHB会导致GHB信号系统发生显著的可塑性改变,假定结合位点(TSPAN17)下调,而ALDH5A1过表达,尤其是在海马神经元中。我们的研究结果进一步表明,这些脑区中的GABA-A和GABA-B受体下调,导致GABA-B表达下降幅度更大。

结论

从法医病理学角度来看,本研究的目的是提供一种新的方法策略,以更好地理解这种有争议物质的特性,这可能有助于我们更好地掌握其滥用情况背后的未知机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14a/10536195/209105509218/pharmaceuticals-16-01225-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验